(PRESS RELEASE) LONDON, 27-Mar-2019 — /EuropaWire/ — The LentiGlobin application for Conditional Marketing Authorization (cMAA) at the EMA from bluebird bio is still in the process of being reviewed by CHMP during their 25-28 March 2019 meeting. An opinion for … Read the full press release
Posted in European Union, Healthcare, Italy, News, Pharma & Biotech, Science
Tagged AVLT, CHMP, cMAA, Dr. Chris Sotirelis, Dr. Michele Lipucci di Paola, EMA, gene therapy, LentiGlobin, Thalassaemia, UKTS
(PRESS RELEASE) STUTTGART, 27-Mar-2019 — /EuropaWire/ — Bosch will be presenting an autonomous transport system, artificial intelligence (AI) based visual fault detection and 3D printing relying on 5G at Hannover Messe. The factory of the future has already become a … Read the full press release
Posted in Artificial Intelligence (AI), Automotive, Electronics & Machinery, Germany, Industrial, News, Sweden, Technology
Tagged 3D printer, 5G, 5G standard, 5G-ACIA, AI, Andreas Müller, APAS, AQUIAS, artificial-intelligence, autonomous transport, BigRep, Bosch, Bosch Industry 4.0 solutions, data transmission, Factory of the Future, greater productivity, Hägglunds, Hannover Messe, high-performance hydraulic systems, Inclusion, Industry 4.0, Kiruna, LKAB, machine learning methods, machines, Mellansel, Nokia, Qualcomm, Rexroth, robotics, Rolf Najork, Sweden, ViPAS, visual quality control
(PRESS RELEASE) LONDON, 27-Mar-2019 — /EuropaWire/ — A joint venture between Schroders plc and Lloyds Banking Group plc, Schroders Personal Wealth announces its executive team. Schroders Personal Wealth will be launched later this year with the aim to help more … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
